Weng KP - Search Results

1

Symptom-correlated MiRNA signature as a potential biomarker for Kawasaki disease.

Chen CC, Chu HY, Chang IY, Chang YS, Weng KP, Chang LS, Liu SF, Kuo HC. Chen CC, et al. Among authors: weng kp. Biomed J. 2023 Dec 10:100684. doi: 10.1016/j.bj.2023.100684. Online ahead of print. Biomed J. 2023. PMID: 38086470 Free article. No abstract available.

2

Next-generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease.

Kuo HC, Hsieh KS, Ming-Huey Guo M, Weng KP, Ger LP, Chan WC, Li SC. Kuo HC, et al. Among authors: weng kp. J Allergy Clin Immunol. 2016 Oct;138(4):1227-1230. doi: 10.1016/j.jaci.2016.04.050. Epub 2016 Jun 18. J Allergy Clin Immunol. 2016. PMID: 27450727 Free article. No abstract available.

3

A novel score system of blood tests for differentiating Kawasaki disease from febrile children.

Tsai CM, Chu CH, Liu X, Weng KP, Liu SF, Huang YH, Kuo HC. Tsai CM, et al. Among authors: weng kp. PLoS One. 2021 Jan 22;16(1):e0244721. doi: 10.1371/journal.pone.0244721. eCollection 2021. PLoS One. 2021. PMID: 33481812 Free PMC article.

4

Desquamation in Kawasaki Disease.

Chang LS, Weng KP, Yan JH, Lo WS, Guo MM, Huang YH, Kuo HC. Chang LS, et al. Among authors: weng kp. Children (Basel). 2021 Apr 21;8(5):317. doi: 10.3390/children8050317. Children (Basel). 2021. PMID: 33919412 Free PMC article.

5

Long-Term Hypermethylation of FcγR2B in Leukocytes of Patients with Kawasaki Disease.

Chang LS, Yu HR, Chu CL, Chen KD, Huang YH, Guo MM, Weng KP, Kuo HC. Chang LS, et al. Among authors: weng kp. J Clin Med. 2021 May 27;10(11):2347. doi: 10.3390/jcm10112347. J Clin Med. 2021. PMID: 34071896 Free PMC article.

6

Prediction Model for Diagnosis of Kawasaki Disease Using iTRAQ-Based Analysis.

Weng KP, Li SC, Chien KJ, Tsai KW, Kuo HC, Hsieh KS, Huang SH. Weng KP, et al. Children (Basel). 2021 Jul 5;8(7):576. doi: 10.3390/children8070576. Children (Basel). 2021. PMID: 34356555 Free PMC article.

7

Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays.

Kuo HC, Kuo KC, Du PX, Keskin BB, Su WY, Ho TS, Tsai PS, Pau CH, Shih HC, Huang YH, Weng KP, Syu GD. Kuo HC, et al. Among authors: weng kp. Mol Cell Proteomics. 2023 Apr;22(4):100507. doi: 10.1016/j.mcpro.2023.100507. Epub 2023 Feb 12. Mol Cell Proteomics. 2023. PMID: 36787877 Free PMC article.

8

Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays.

Keskin BB, Liu SF, Du PX, Tsai PS, Ho TS, Su WY, Lin PC, Shih HC, Weng KP, Yang KD, Huang YH, Kuo KC, Syu GD, Kuo HC. Keskin BB, et al. Among authors: weng kp. Analyst. 2023 Sep 25;148(19):4698-4709. doi: 10.1039/d3an00802a. Analyst. 2023. PMID: 37610260

9

Recent advances in the treatment of Kawasaki disease.

Weng KP, Ou SF, Lin CC, Hsieh KS. Weng KP, et al. J Chin Med Assoc. 2011 Nov;74(11):481-4. doi: 10.1016/j.jcma.2011.09.001. Epub 2011 Nov 4. J Chin Med Assoc. 2011. PMID: 22100015 Free article. Review.

10

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.

Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP. Weng KP, et al. Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11. Kaohsiung J Med Sci. 2012. PMID: 22226058 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page